BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 33228786)

  • 1. Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer's disease.
    Shi H; Koronyo Y; Fuchs DT; Sheyn J; Wawrowsky K; Lahiri S; Black KL; Koronyo-Hamaoui M
    Acta Neuropathol Commun; 2020 Nov; 8(1):202. PubMed ID: 33228786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina.
    Shi H; Koronyo Y; Rentsendorj A; Regis GC; Sheyn J; Fuchs DT; Kramerov AA; Ljubimov AV; Dumitrascu OM; Rodriguez AR; Barron E; Hinton DR; Black KL; Miller CA; Mirzaei N; Koronyo-Hamaoui M
    Acta Neuropathol; 2020 May; 139(5):813-836. PubMed ID: 32043162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.
    Perez SE; Lumayag S; Kovacs B; Mufson EJ; Xu S
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):793-800. PubMed ID: 18791173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plastic roles of pericytes in the blood-retinal barrier.
    Park DY; Lee J; Kim J; Kim K; Hong S; Han S; Kubota Y; Augustin HG; Ding L; Kim JW; Kim H; He Y; Adams RH; Koh GY
    Nat Commun; 2017 May; 8():15296. PubMed ID: 28508859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
    Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
    J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.
    Chidlow G; Wood JP; Manavis J; Finnie J; Casson RJ
    J Alzheimers Dis; 2017; 56(2):655-675. PubMed ID: 28035930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal Vasculopathy in Alzheimer's Disease.
    Shi H; Koronyo Y; Rentsendorj A; Fuchs DT; Sheyn J; Black KL; Mirzaei N; Koronyo-Hamaoui M
    Front Neurosci; 2021; 15():731614. PubMed ID: 34630020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular pathology during the progression of experimental Alzheimer's disease.
    Giannoni P; Arango-Lievano M; Neves ID; Rousset MC; Baranger K; Rivera S; Jeanneteau F; Claeysen S; Marchi N
    Neurobiol Dis; 2016 Apr; 88():107-17. PubMed ID: 26774030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy.
    Gustafsson S; Gustavsson T; Roshanbin S; Hultqvist G; Hammarlund-Udenaes M; Sehlin D; Syvänen S
    Neuropharmacology; 2018 Dec; 143():1-9. PubMed ID: 30201212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.
    Liu B; Rasool S; Yang Z; Glabe CG; Schreiber SS; Ge J; Tan Z
    Am J Pathol; 2009 Nov; 175(5):2099-110. PubMed ID: 19834067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's Retinopathy: Seeing Disease in the Eyes.
    Mirzaei N; Shi H; Oviatt M; Doustar J; Rentsendorj A; Fuchs DT; Sheyn J; Black KL; Koronyo Y; Koronyo-Hamaoui M
    Front Neurosci; 2020; 14():921. PubMed ID: 33041751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).
    Kielczewski JL; Li Calzi S; Shaw LC; Cai J; Qi X; Ruan Q; Wu L; Liu L; Hu P; Chan-Ling T; Mames RN; Firth S; Baxter RC; Turowski P; Busik JV; Boulton ME; Grant MB
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8278-86. PubMed ID: 21931131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal arterial Aβ
    Shi H; Koronyo Y; Fuchs DT; Sheyn J; Jallow O; Mandalia K; Graham SL; Gupta VK; Mirzaei M; Kramerov AA; Ljubimov AV; Hawes D; Miller CA; Black KL; Carare RO; Koronyo-Hamaoui M
    Alzheimers Dement; 2023 Nov; 19(11):5185-5197. PubMed ID: 37166032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
    Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
    J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age dependence of retinal vascular plexus attenuation in the triple transgenic mouse model of Alzheimer's disease.
    Nazari HK; Karimaghaei C; van der Merwe R; Montalbano M; Taglialatela G; Vargas G; Zhang W; Motamedi M
    Exp Eye Res; 2022 Jan; 214():108879. PubMed ID: 34896306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse.
    Gupta VK; Chitranshi N; Gupta VB; Golzan M; Dheer Y; Wall RV; Georgevsky D; King AE; Vickers JC; Chung R; Graham S
    Neurosci Lett; 2016 Jun; 623():52-6. PubMed ID: 27133194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
    Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
    Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature.
    Zhang C; Lai MB; Pedler MG; Johnson V; Adams RH; Petrash JM; Chen Z; Junge HJ
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2691-2705. PubMed ID: 30354230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.